1. (1) A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Drug Administration for the reversal of an opioid overdose if the drug is:

   1. (a) In the form of a nasal spray; and
   2. (b) Personally dispensed by a health care provider described in this subsection at the location of practice of the health care provider.

2. (2) The information described in subsection (1) of this section includes:

   1. (a) The name of the patient;
   2. (b) The name and address of the dispensing health care provider;
   3. (c) The date of dispensing;

   4. (d)

      1. (A) The name of the drug or, if the dispensed drug does not have a brand name, the generic name of the drug along with the name of the drug distributor or manufacturer;
      2. (B) The drug’s quantity per unit, unless the drug is a compound; and
      3. (C) The directions for the drug’s use stated in the prescription;
   5. (e) Cautionary statements, if any, as required by law; and
   6. (f) When applicable and as determined by the State Board of Pharmacy, an expiration date after which the patient should not use the drug.

[2023 c.285 §2]